Patents Represented by Attorney Colett C. Incyte Pharmaceuticals, Inc. Muenzen
  • Patent number: 6043222
    Abstract: The invention provides a two new human DnaJ-like proteins (HSPJ1 or HSPJ2) and polynucleotides which identify and encode HSPJ1 or HSPJ2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HSPJ1 or HSPJ2.
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: March 28, 2000
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Janice Au-Young, Preeti Lal, Olga Bandman